Paul F. Lebeau
The Research Institute Of St Joe's Hamilton And The Hamilton Centre For Kidney Research
Hamilton, ON, Canada
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Correction: Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
Journal: The Journal of biological chemistry
Published: August 15, 2025
Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease.
Journal: Nature reviews. Nephrology
Published: January 27, 2025
GDF10 is a negative regulator of vascular calcification.
Journal: The Journal of biological chemistry
Published: April 03, 2024
Repurposing Two Old Friends to Fight Cancer: Caffeine and Statins.
Journal: Cancer research
Published: May 04, 2023
A Metabolic Enhancer Protects against Diet-Induced Obesity and Liver Steatosis and Corrects a Pro-Atherogenic Serum Profile in Mice.
Journal: Nutrients
Published: April 10, 2023
Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin.
Journal: The Journal of biological chemistry
Published: April 08, 2021
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 16, 2021
Calcium as a reliable marker for the quantitative assessment of endoplasmic reticulum stress in live cells.
Journal: The Journal of biological chemistry
Published: December 17, 2020
Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance.
Journal: Nature communications
Published: August 17, 2020
TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: May 22, 2020
Last Updated: 09/26/2026